A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-017-1972-x
Published Online: 2017-06-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kassimatis, Theodoros
Qasem, Anass
Douiri, Abdel
Ryan, Elizabeth G.
Rebollo-Mesa, Irene
Nichols, Laura L.
Greenlaw, Roseanna
Olsburgh, Jonathon
Smith, Richard A.
Sacks, Steven H.
Drage, Martin
Funding for this research was provided by:
Medical Research Council (G100197/1)